End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,100.93 PKR | +6.57% |
|
+13.26% | -11.06% |
05-02 | Abbott Laboratories Limited Announces Change of Director, Effective May 5, 2025 | CI |
05-01 | Abbott Laboratories Limited Reports Earnings Results for the First Quarter Ended March 31, 2025 | CI |
Capitalization | 106B 374M 319M 298M 274M 511M 32.1B 575M 3.56B 1.36B 14.97B 1.4B 1.37B 54.58B | P/E ratio 2023 |
172x | P/E ratio 2024 | 23.2x |
---|---|---|---|---|---|
Enterprise value | 100B 353M 301M 281M 258M 481M 30.25B 541M 3.35B 1.28B 14.11B 1.32B 1.3B 51.44B | EV / Sales 2023 |
0.72x | EV / Sales 2024 | 1.69x |
Free-Float |
16.36% | Yield 2023 * |
-
| Yield 2024 | 0.81% |
More valuation ratios
* Estimated data
More news
More press releases
1 day | +6.57% | ||
1 week | +13.26% | ||
Current month | +13.26% | ||
1 month | +17.16% | ||
3 months | +4.16% | ||
6 months | -10.59% | ||
Current year | -11.06% |
1 week | 984.98 | ![]() | 1,105 |
1 month | 925.02 | ![]() | 1,105 |
Current year | 790 | ![]() | 1,310 |
1 year | 673.01 | ![]() | 1,310 |
3 years | 330 | ![]() | 1,310 |
5 years | 330 | ![]() | 1,310 |
10 years | 302.1 | ![]() | 1,310 |
Manager | Title | Age | Since |
---|---|---|---|
Syed Anis Ahmed
CEO | Chief Executive Officer | - | 2016-03-31 |
Director of Finance/CFO | - | 2019-10-31 | |
Raeef Ahmed
CTO | Chief Tech/Sci/R&D Officer | - | 2011-05-31 |
Director | Title | Age | Since |
---|---|---|---|
Syed Anis Ahmed
BRD | Director/Board Member | - | 2009-02-28 |
Seema Khan
BRD | Director/Board Member | - | 2014-06-03 |
Ehsan Ali Malik
CHM | Chairman | - | 2022-05-29 |
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
+6.57% | +13.26% | +41.14% | +66.29% | 379M | ||
+2.22% | +1.53% | -14.19% | +138.37% | 694B | ||
+0.79% | +0.40% | +7.61% | -12.19% | 374B | ||
+1.95% | +0.66% | +14.84% | +25.11% | 331B | ||
+1.75% | +1.87% | -54.65% | +11.78% | 308B | ||
+0.06% | -1.50% | +5.38% | -20.22% | 259B | ||
+0.07% | -0.28% | +0.42% | +17.97% | 240B | ||
+1.29% | -0.60% | -14.15% | -6.37% | 216B | ||
+1.30% | +0.08% | -34.91% | -11.75% | 203B | ||
+1.27% | +2.25% | -4.63% | +19.55% | 158B | ||
Average | +1.74% | +2.56% | -5.31% | +22.85% | 278.32B | |
Weighted average by Cap. | +1.35% | +0.90% | -10.17% | +36.58% |
2023 | 2024 | |
---|---|---|
Net sales | 55.48B 195M 166M 156M 143M 266M 16.75B 300M 1.85B 707M 7.81B 732M 717M 28.47B | 68.18B 240M 205M 191M 176M 327M 20.58B 368M 2.28B 869M 9.6B 900M 881M 34.99B |
Net income | 262M 921K 785K 734K 675K 1.26M 79.02M 1.41M 8.75M 3.34M 36.85M 3.46M 3.38M 134M | 5.23B 18.42M 15.7M 14.68M 13.5M 25.14M 1.58B 28.28M 175M 66.71M 737M 69.09M 67.66M 2.69B |
Net Debt | -4.88B -17.17M -14.63M -13.68M -12.58M -23.43M -1.47B -26.36M -163M -62.18M -687M -64.39M -63.06M -2.5B | -6.13B -21.57M -18.39M -17.19M -15.81M -29.44M -1.85B -33.12M -205M -78.13M -863M -80.91M -79.24M -3.15B |
More financial data
* Estimated data
Employees
1,406
Sector
Pharmaceuticals
Date | Price | Change | Volume |
---|---|---|---|
25-07-08 | 1,086.23 ₨ | -1.34% | 33,922 |
25-07-07 | 1,100.93 ₨ | +6.57% | 102,736 |
25-07-04 | 1,033.08 ₨ | -0.15% | 4,585 |
25-07-03 | 1,034.60 ₨ | +1.22% | 21,601 |
25-07-02 | 1,022.11 ₨ | +4.22% | 56,836 |
End-of-day quote Pakistan S.E., July 06, 2025
More quotes- Stock Market
- Equities
- ABOT Stock
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition